NCT00968539View on ClinicalTrials.gov

Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

September 8, 2009

Primary Completion Date

September 28, 2010

Study Completion Date

September 28, 2010

Conditions
Influenza
Interventions
BIOLOGICAL

GSK investigational vaccine GSK2340272A

Two intramuscular injections

BIOLOGICAL

GSK investigational vaccine GSK2340269A

Two intramuscular injections

Trial Locations (1)

9000

GSK Investigational Site, Ghent

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00968539 - Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults | Biotech Hunter | Biotech Hunter